Palisade Bio (PALI) Stock Price
Palisade Bio Price
Revenue at Palisade Bio has contracted by 0.4% per year over the past 17 years to 250,000.00 USD. For Palisade Bio, the net margin of -4,920.0% is down versus -1,894.2% a few years ago. The consensus 12-month price target for Palisade Bio is 4.50 USD, about 199.0% above where the stock trades today. Of 16 analysts, 15 rate the stock a buy — an overall Buy consensus.
Palisade Bio stock price
Palisade Bio business model & stock analysis
Frequently asked questions about Palisade Bio
Analysts currently set an average price target of 4.50 USD for the Palisade Bio stock (median: 4.50 USD), implying +199.0 % versus the latest price. The consensus is based on 16 analyst ratings.
16 analysts currently rate the Palisade Bio stock: 15 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Palisade Bio to generate revenue of 428,571.00 USD and earnings per share of -0.01 USD.
Converted at the current exchange rate, the Palisade Bio share trades at 1.34 EUR (1.50 USD).
The Palisade Bio share (PALI) is listed on 3 stock exchanges, including: NASDAQ (PALI), Frankfurt (7NS.F), München (7NS.MU).
The expected revenue of Palisade Bio is 428,571.00 USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Palisade Bio is -321,078.03 USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Palisade Bio is currently -260.94. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Palisade Bio stock.
The price-to-sales ratio (P/S) of Palisade Bio is currently 195.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Palisade Bio stock.
The Eulerpool Quality Score for Palisade Bio is 1/10.
The ISIN of Palisade Bio is US6963894026. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Palisade Bio is A3DZ0T. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Palisade Bio is PALI. The ticker symbol is used to trade Palisade Bio shares on the stock exchange.
Palisade Bio stock
Palisade Bio Peer Group
Palisade Bio Ticker
All fundamentals and in-depth analysis of Palisade Bio
Our stock analysis for Palisade Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Palisade Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.